Pralatrexate and Gemcitabine in Patients with Relapsed or Refractory Lymphoproliferative Malignancies: Phase 1 Results. Horwitz, S. M., Vose, J. M., Advani, R., Sankhala, K., Padmanabhan, S., Hamlin, P. A., Chen, A., Zain, J. M., Fruchtman, S., O'Connor, O. A. AMER SOC HEMATOLOGY. 2009: 667–68

View details for Web of Science ID 000272725802042